fk 1052 has been researched along with zidovudine in 1 studies
Studies (fk 1052) | Trials (fk 1052) | Recent Studies (post-2010) (fk 1052) | Studies (zidovudine) | Trials (zidovudine) | Recent Studies (post-2010) (zidovudine) |
---|---|---|---|---|---|
12 | 0 | 2 | 10,180 | 1,399 | 1,188 |
Protein | Taxonomy | fk 1052 (IC50) | zidovudine (IC50) |
---|---|---|---|
Thymidine kinase, cytosolic | Homo sapiens (human) | 3 | |
Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 0.6633 | |
Protease | Human immunodeficiency virus 1 | 0.015 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kagayama, A; Naritomi, Y; Sugiyama, Y; Terashita, S | 1 |
1 other study(ies) available for fk 1052 and zidovudine
Article | Year |
---|---|
Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro.
Topics: Acetaminophen; Animals; Benzodiazepinones; Chromans; Cryopreservation; Diazepam; Diltiazem; Hepatocytes; Humans; Imidazoles; In Vitro Techniques; Indoles; Metabolic Clearance Rate; Predictive Value of Tests; Quinolizines; Rats; Reproducibility of Results; Species Specificity; Tetrazoles; Thiazolidinediones; Time Factors; Troglitazone; Zidovudine | 2003 |